DeviceClearance

K896368

Substantially Equivalent

MODIFIED AXOSTIM

Applicant
Singer Medical Products, Inc.
Product code
BXN
Advisory panel
Anesthesiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Bensenville, IL, US
Download summary PDF View on FDA.gov ↗

Adverse events under product code BXN

product code BXN
Other
1
Total
1

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.